Document:

Warrant 1 to M.A.G. Capital, LLC

 Exhibit 10.23 
 WARRANT TO PURCHASE COMMON STOCK 
 THIS WARRANT AND THE SECURITIES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE STATE
SECURITIES LAWS OR THE AVAILABILITY OF AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
 WARRANT TO PURCHASE COMMON STOCK 
  

			
	Number of Shares:	  	Up to 3,250,000 Shares (subject to adjustment)
		
	Warrant Price:	  	$1.1382 per Share
		
	Issuance Date:	  	September 20, 2006
		
	Expiration Date:	  	September 20, 2011

 THIS WARRANT CERTIFIES THAT for value received, M.A.G. Capital, LLC, or its registered assigns (hereinafter
called the “Holder”) is entitled to purchase from Diametrics Medical, Inc., a Minnesota corporation (hereinafter called the “Company”), the above referenced number of fully paid and nonassessable
shares (the “Shares”) of common stock, par value $1.00 per share (the “Common Stock”) of Company, at the Warrant Price per Share referenced above; the number of shares purchasable upon exercise of this
Warrant referenced above being subject to adjustment from time to time as described herein. This Warrant is issued in connection with that certain Warrant Subscription Agreement dated as of September 20, 2006, by and between the Company and
Holder (the “Subscription Agreement”). The exercise of this Warrant shall be subject to the provisions, limitations and restrictions contained herein. 
 1. Term and Exercise. 
 1.1 Term. This Warrant is exercisable in whole or in part (but not as to
any fractional share of Common Stock), at any time and from time to time after the later of (x) the date that is six months after the Issuance Date and (y) the date of approval (the “Shareholder Approval Date”) by the
shareholders of the Company of either (i) an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the number of shares of Common Stock that the Company is authorized to issue or (ii) the merger of the
Company into a wholly owned subsidiary of the Company incorporated in the State of Delaware, in either case resulting in a sufficient number of authorized shares for the Company to reserve a sufficient number of shares of authorized but unissued
shares of Common Stock issuable upon exercise of this Warrant, but prior to 6:00 p.m. (New York Time) on the Expiration Date set forth above. 
 1.2
Warrant Price. The Warrant shall be exercisable at the Warrant Price referenced above. 
 1.3 Maximum Number of Shares. The maximum
number of Shares of Common Stock exercisable pursuant to this Warrant is 3,250,000 Shares, subject to adjustment as set forth herein. However, notwithstanding anything herein to the contrary, in no event shall the Holder be permitted to exercise
this Warrant for a number of Shares greater than the number that would cause the aggregate beneficial ownership of the Company’s Common Stock (calculated pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of the Holder
and all persons affiliated with the Holder to equal 9.99% of the Company’s Common Stock then outstanding; provided that the Holder shall be responsible for any calculation required for compliance with such 9.99% limit and shall provide the
Company with a certificate setting forth such calculation at the time of any exercise of this Warrant in whole or in part. 
 1.4 Procedure for
Exercise of Warrant. Holder may exercise this Warrant by delivering the following to the principal office of the Company in accordance with Section 5.1 hereof: (i) a duly executed Notice of Exercise in substantially the form
attached as Schedule A and the certificate described in Section 1.3 hereof, (ii) payment of the Warrant Price then in effect for each of the Shares being purchased, as designated in the Notice of Exercise, and (iii) this Warrant.
Payment of the Warrant Price may be in cash, certified or official bank check payable to the order of the Company, or wire transfer of funds to the Company’s account (or any combination of any of the foregoing) in the amount of the Warrant
Price for each share being purchased. 
 1.5 Delivery of Certificate and New Warrant. In the event of any exercise of the rights represented by
this Warrant, a certificate or certificates for the shares of Common Stock so purchased, registered in the name of the Holder or such other name or names as may be designated by the Holder, together with any other securities or other property which
the Holder is entitled to receive upon exercise of this Warrant, shall be delivered to the Holder hereof, at the Company’s expense, within a reasonable time, not exceeding five (5) trading days, after the rights represented by this Warrant
shall have been so exercised; and, unless this Warrant has expired, a new Warrant representing the number of Shares (except a remaining fractional share), if any, with respect to which this Warrant shall not then have been exercised shall also be
issued to the Holder hereof within such time. The person in whose name any certificate for shares of Common Stock is issued upon exercise of this Warrant shall for all purposes be deemed to have become the holder of record of such shares on the date
on which the Warrant was surrendered and payment of the Warrant Price was received by the Company, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is on a date when the stock transfer
books of the Company are closed, such person shall be deemed to have become the holder of such Shares at the close of business on the next succeeding date on which the stock transfer books are open. 
 1.6 Restrictive Legend. Each certificate for Shares shall bear a restrictive legend in substantially the form as follows, together with any additional
legend required by (i) any applicable state securities laws and (ii) any securities exchange upon which such Shares may, at the time of such exercise, be listed: 
 “The shares represented by this certificate have not been registered under the Securities Act of 1933, as amended and may not be sold, offered for sale, transferred or pledged in the absence of such registration
or an exemption therefrom under such Act.” 
 Any certificate issued at any time in exchange or substitution for any certificate bearing such legend
shall also bear such legend unless, in the opinion of counsel for the Holder thereof (which counsel shall be reasonably satisfactory to the Company), the securities represented thereby are not, at such time, required by law to bear such legend.

 1.7 Fractional Shares. No fractional Shares shall be issuable upon exercise or conversion of the Warrant.
If a fractional share interest arises upon any exercise or conversion of the Warrant, the Company shall round up the number of Shares to be issued to the nearest whole Share and the Holder shall increase the consideration due upon exercise by an
amount computed by multiplying such fractional interest by the Warrant Price of a full Share then in effect. 
 1.8 Cashless Exercise.

 (a) Holder may, at its option, in lieu of paying the Warrant Price upon exercise of this Warrant pursuant to Section 1.4 hereof, elect
to receive instead a number of Shares computed using the following formula: 
 X=Y(A-B) 
          A 
 Where X= the number of Shares issuable to Holder upon exercise of this Warrant under this Section 1.8, Y=the number of Shares for which this Warrant is then being exercised, in whole or in part, A=the Fair Market
Value (as defined below) of one Share of Common Stock as of the exercise date; and B=the Warrant Price of one Share of Common Stock. 
 (b)
For purposes of this Section 1.8, “Fair Market Value” of one Share of Common Stock as of a particular date shall be determined as follows: (i) if traded on a national securities exchange or through the Nasdaq Stock
Market, the Fair Market Value shall be deemed to be the volume weighted average closing price of the Common Stock on such exchange for the five trading days immediately prior to the date the Holder delivers its Notice of Exercise to the Company (or
if no reported sales took place on any of the five days, the last five trading days on which any such sales took place prior to the date of such notice); (ii) if traded over-the-counter but not on the Nasdaq Stock Market, the Fair Market Value
shall be deemed to be the volume weighted average closing price of the Common Stock on such exchange for the five trading days immediately prior to the date the Holder delivers its Notice of Exercise to the Company (or if no reported sales took
place on any of the five days, the last five trading days on which any such sales took place prior to the date of such notice); and (iii) if not then traded on any public market, the Fair Market Value shall be the as mutually determined by the
Holder and the Company or, if the Holder and the Company are unable to reach such agreement, as determined by a nationally recognized independent investment banker or valuation consultant (which has not been retained by the Company or any of its
affiliates for the past two years preceding such determination) mutually acceptable to Holder and Company. 
 2. Representations, Warranties and
Covenants. 
 2.1 Representations and Warranties. 
 (a) The Company is a corporation duly organized, validly existing and in good standing under the laws of its state of incorporation and has all necessary power and authority to perform its obligations under this
Warrant; 
 (b) Subject to the Shareholder Approval, the execution, delivery and performance of this Warrant has been duly authorized by all
necessary actions on the part of the Company and constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms; and 
 (c) Subject to the Shareholder Approval, this Warrant does not violate and is not in conflict with any of the provisions of the Company’s Amended
and Restated Articles of Incorporation, Certificate of Designation, Bylaws and any resolutions of the Company’s Board of Directors or stockholders, or any agreement of the Company, and no event has occurred and no condition or circumstance
exists that might (with or without notice or lapse of time) constitute or result directly or indirectly in such a violation or conflict. 
 2.2
Issuance of Shares. The Company covenants and agrees that all shares of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be validly issued, fully paid and nonassessable, and
free from all taxes, liens and charges with respect to the issue thereof and shall be listed on any exchanges on which the Common Stock is then listed. The Company further covenants and agrees that it will pay when due and payable any and all
federal and state taxes which may be payable in respect of the issue of this Warrant or any Common Stock or certificates therefor issuable upon the exercise of this Warrant excluding the Holder’s income and other taxes not directly relating to
the issuance of the Warrant or Common Stock. The Company further covenants and agrees that the Company will at all times when this Warrant is exercisable have authorized and reserved, free from preemptive rights, a sufficient number of shares of
Common Stock to provide for the exercise in full of the rights represented by this Warrant. If at any time when this Warrant is exercisable the number of authorized but unissued shares of Common Stock of the Company shall not be sufficient to effect
the exercise of the Warrant in full, subject to the limitations set forth in Section 1.3 hereto, then the Company will use commercially reasonable efforts to take all such corporate action as may, in the opinion of counsel to the Company, be
necessary or advisable to increase the number of its authorized shares of Common Stock as shall be sufficient to permit the exercise of the Warrant in full, subject to the limitations set forth in Section 1.3 hereto, including without
limitation, using its commercially reasonable efforts to obtain any necessary stockholder approval of such increase. The Company further covenants and agrees that if any shares of capital stock to be reserved for the purpose of the issuance of
shares upon the exercise of this Warrant require registration with or approval of any governmental authority under any federal or state law before such shares may be validly issued or delivered upon exercise, then the Company will in good faith and
as expeditiously as possible endeavor to secure such registration or approval, as the case may be. Notwithstanding the foregoing, at the date of execution of this Warrant, the Corporation does not have sufficient authorized but unissued shares of
Common Stock for the purpose of effecting the conversion of this Warrant, and the Corporation will use commercially reasonable efforts to obtain the Shareholder Approval. If and so long as the Common Stock issuable upon the exercise of this Warrant
is listed on any national securities exchange or the Nasdaq Stock Market, the Company will, if permitted by the rules of such exchange or market, list and keep listed on such exchange or market, upon official notice of issuance, all shares of such
Common Stock issuable upon exercise of this Warrant. 
 3. Other Adjustments. 
 3.1 Subdivision or Combination of Shares. In case the Company shall at any time subdivide its outstanding Common Stock into a greater number of shares, the Warrant Price in effect immediately prior to
such subdivision shall be proportionately reduced, and the number of Shares subject to this Warrant shall be proportionately increased, and conversely, in case the outstanding Common Stock of the Company shall be combined into a smaller number of
shares, the Warrant Price in effect immediately prior to such combination shall be proportionately increased, and the number of Shares subject to this Warrant shall be proportionately decreased. 
 3.2 Dividends in Common Stock, Other Stock or Property. If at any time or from time to time the holders of Common Stock (or any shares of stock or other
securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled to receive, without payment therefor: 
 (a) Common Stock, Options or any shares or other securities which are at any time directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the
foregoing by way of dividend or other distribution; 
 (b) any cash paid or payable otherwise than as a regular cash dividend; or 

 

 -2- 

 (c) Common Stock or additional shares or other securities or property (including cash) by way of
spin-off, split-up, reclassification, combination of shares or similar corporate rearrangement (other than adjustments covered by the terms of Section 3.1 above or Section 3.3 below), then and in each such case (but without duplication),
the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other
securities and property (including cash in the cases referred to in clause (b) above and this clause (c)) which such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on
which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property. 
 3.3
Reorganization, Reclassification, Consolidation, Merger or Sale. If any recapitalization, reclassification or reorganization of the share capital of the Company, or any consolidation or merger of the Company with another corporation, or
the sale of all or substantially all of its shares and/or assets or other transaction (including, without limitation, a sale of substantially all of its assets followed by a liquidation) shall be effected in such a way that holders of Common Stock
shall be entitled to receive shares, securities or other assets or property (a “Change”), then, as a condition of such Change, lawful and adequate provisions shall be made by the Company whereby the Holder hereof shall
thereafter have the right to purchase and receive (in lieu of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby) such shares, securities or other assets or property
as may be issued or payable with respect to or in exchange for the number of outstanding shares of Common Stock which such Holder would have been entitled to receive had such Holder exercised this Warrant immediately prior to the consummation of
such Change. The Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to give effect
to the adjustments provided for in this Section 3 including, without limitation, adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new Warrant. The provisions of this Section 3.3
shall similarly apply to successive Changes. 
 4. Ownership and Transfer. 
 4.1 Ownership of This Warrant. The Company may deem and treat the person in whose name this Warrant is registered as the holder and owner hereof (notwithstanding any notations of ownership or writing
hereon made by anyone other than the Company) for all purposes and shall not be affected by any notice to the contrary until presentation of this Warrant for registration of transfer as provided in this Section 4. 
 4.2 Transfer and Replacement. This Warrant and all rights hereunder are transferable in whole or in part upon the books of the Company by the Holder hereof
in person or by duly authorized attorney, and a new Warrant or Warrants, of the same tenor as this Warrant but registered in the name of the transferee or transferees (and in the name of the Holder, if a partial transfer is effected) shall be made
and delivered by the Company upon surrender of this Warrant duly endorsed, at the office of the Company in accordance with Section 5.1 hereof. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft or
destruction, and, in such case, of indemnity or security reasonably satisfactory to it, and upon surrender of this Warrant if mutilated, the Company will make and deliver a new Warrant of like tenor, in lieu of this Warrant; provided that if the
Holder hereof is an instrumentality of a state or local government or an institutional holder or a nominee for such an instrumentality or institutional holder an irrevocable agreement of indemnity by such Holder shall be sufficient for all purposes
of this Warrant, and no evidence of loss or theft or destruction shall be necessary. This Warrant shall be promptly cancelled by the Company upon the surrender hereof in connection with any transfer or replacement. In the case of the loss, theft or
destruction of a Warrant, the Holder shall pay all expenses, taxes and other charges payable in connection with any transfer or replacement of this Warrant. Holder will not transfer this Warrant and the rights hereunder except in compliance with
federal and state securities laws and except after providing evidence of such compliance reasonably satisfactory to the Company. 
 5. Miscellaneous
Provisions. 
 5.1 Notices. Any notice or other document required or permitted to be given or delivered to the Holder shall be delivered
or forwarded to the Holder at c/o M.A.G. Capital, LLC, 555 South Flower Street, Suite 4200, Los Angeles, California 90071, Attention: David F. Firestone (Facsimile No. 213/553-8285), or to such other address or number as shall have been
furnished to the Company in writing by the Holder, with a copy to Latham & Watkins LLC, 633 West Fifth Street, Suite 4000, Los Angeles, California 90071-1448 Attention: Paul Tosetti (Facsimile No. 213/891-8763). Any notice or other
document required or permitted to be given or delivered to the Company shall be delivered or forwarded to the Company at 6033 West Century Blvd., Suite 850, Los Angeles, CA 90045 (facsimile No. (310) 670-4107), with a copy to
Sidley Austin LLP, 555 West Fifth Street, 40th Floor, Los Angeles, California 90013, Attention: Stephen D. Blevit
(Facsimile No. 213/896-6600), or to such other address or number as shall have been furnished to Holder in writing by the Company or to the Company by Holder. 
 5.2 All notices, requests and approvals required by this Warrant shall be in writing and shall be conclusively deemed to be given (i) when hand-delivered to the other party, (ii) when received if sent by facsimile at the
address and number set forth above; provided that notices given by facsimile shall not be effective, unless either (a) a duplicate copy of such facsimile notice is promptly given by depositing the same in the mail, postage prepaid and addressed
to the party as set forth below or (b) the receiving party delivers a written confirmation of receipt for such notice by any other method permitted under this paragraph; and further provided that any notice given by facsimile received after
5:00 p.m. (New York Time) or on a non-business day shall be deemed received on the next business day; (iii) five (5) business days after deposit in the United States mail, certified, return receipt requested, postage prepaid, and addressed
to the party as set forth below; or (iv) the next business day after deposit with an international overnight delivery service, postage prepaid, addressed to the party as set forth below with next business day delivery guaranteed; provided that
the sending party receives confirmation of delivery from the delivery service provider. 
 5.3 No Rights as Shareholder; Limitation of
Liability. This Warrant shall not entitle the Holder to any of the rights of a shareholder of the Company except upon exercise in accordance with the terms hereof. No provision hereof, in the absence of affirmative action by the Holder to
purchase shares of Common Stock, and no mere enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the Warrant Price hereunder or as a shareholder of the Company, whether such liability is
asserted by the Company or by creditors of the Company. 
 5.4 Governing Law. This Warrant shall be governed by and construed in accordance
with the laws of the State of New York. 
 5.5 Binding Effect on Successors. This Warrant shall be binding upon any corporation succeeding the
Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets and/or securities. All of the obligations of the Company relating to the Shares issuable upon the exercise of this Warrant shall survive the
exercise and termination of this Warrant. All of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the Holder. 
  

 -3- 

 5.6 Waiver, Amendments and Headings. This Warrant and any provision hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by both parties (either generally or in a particular instance and either retroactively or prospectively). The headings in this Warrant are for purposes of reference only and shall not
affect the meaning or construction of any of the provisions hereof. 
 5.7 Jurisdiction. Each of the parties irrevocably agrees that any and
all suits or proceedings based on or arising under this Agreement may be brought in the federal or state courts located in the City of New York, New York and consents to the jurisdiction of such courts for such purpose. Each of the parties
irrevocably waives the defense of an inconvenient forum to the maintenance of such suit or proceeding in any such court. Each of the parties further agrees that service of process upon such party mailed by first class mail to the address set forth
in Section 5.1 shall be deemed in every respect effective service of process upon such party in any such suit or proceeding. Nothing herein shall affect the right of a Holder to serve process in any other manner permitted by law. Each of the
parties agrees that a final non-appealable judgment in any such suit or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on such judgment or in any other lawful manner. 
 5.8 Attorneys’ Fees and Disbursements. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the
prevailing party or parties shall be entitled to receive from the other party or parties reasonable attorneys’ fees and disbursements in addition to any other relief to which the prevailing party or parties may be entitled. 
 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer this 20th day of September, 2006. 
  

					
	COMPANY:	 	DIAMETRICS MEDICAL, INC.
			
		 	By:	 	 /s/ W. Bruce Comer III

		 	Print Name:	 	W. Bruce Comer III
		 	Title:	 	Chief Executive Officer

  

 -4- 

 SCHEDULE A 
 FORM OF NOTICE OF EXERCISE 
 [To be signed only upon exercise of the Warrant]

 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO EXERCISE THE WITHIN WARRANT 
 The undersigned hereby elects to purchase
                     shares of Common Stock (the “Shares”) of Diametrics Medical, Inc. under the Warrant to Purchase
Common Stock dated September [15], 2006, which the undersigned is entitled to purchase pursuant to the terms of such Warrant. The undersigned has delivered $            , the
aggregate Warrant Price for                      Shares purchased herewith, in full in cash or by certified or official bank check or wire
transfer. Attached to this Notice of Exercise is a certificate showing the percentage ownership calculation required under Section 1.3 of the Warrant. 
 Please issue a certificate or certificates representing such shares of Common Stock in the name of the undersigned or in such other name as is specified below and in the denominations as is set forth below:

  

	
	 
	[Type Name of Holder as it should appear on the stock certificate]
	 
	[Requested Denominations – if no denomination is specified, a single certificate will be issued]
	
	The initial address of such Holder to be entered on the books of Company shall be:

  

			
	  	  	
	  	  	
	  	  	

 The undersigned hereby represents and warrants that the undersigned is acquiring such shares for
his own account for investment purposes only, and not for resale or with a view to distribution of such shares or any part thereof. 
  

	
	By:                                      
                                        
                  
	
	Print Name:                                    
                                        
   
	
	Title:                                     
                                        
               
	
	Dated:                                     
                                        
             

  

 -1- 

 FORM OF ASSIGNMENT 
 (ENTIRE) 
 [To be signed only upon transfer of entire Warrant] 
 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO TRANSFER THE WITHIN WARRANT 
 FOR VALUE RECEIVED
                             hereby sells, assigns and transfers unto
                             all rights of the undersigned under and pursuant to the within Warrant,
and the undersigned does hereby irrevocably constitute and appoint                             
Attorney to transfer the said Warrant on the books of Diametrics Medical, Inc., with full power of substitution. 
  

			
	  

	[Type Name of Holder]
		
	By:	 	  
  

	Title:	 	  
  

	
	Dated:                     

 NOTICE 
 The
signature to the foregoing Assignment must correspond exactly to the name as written upon the face of the within Warrant, without alteration or enlargement or any change whatsoever. 
  

 -2- 

 FORM OF ASSIGNMENT 
 (PARTIAL) 
 [To be signed only upon partial transfer of Warrant] 
 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO TRANSFER THE WITHIN WARRANT 
 FOR VALUE RECEIVED
                             hereby sells, assigns and transfers unto
                             (i) the rights of the undersigned to purchase
                             shares of Common Stock under and pursuant to the within Warrant, and
(ii) on a non-exclusive basis, all other rights of the undersigned under and pursuant to the within Warrant, it being understood that the undersigned shall retain, severally (and not jointly) with the transferee(s) named herein, all rights
assigned on such non-exclusive basis. The undersigned does hereby irrevocably constitute and appoint
                             Attorney to transfer the said Warrant on the books of Diametrics Medical,
Inc., with full power of substitution. 
  

			
	  
  

	[Type Name of Holder]
		
	By:	 	  
  

	Title:	 	  
  

	
	Dated:                     

 NOTICE 
 The
signature to the foregoing Assignment must correspond exactly to the name as written upon the face of the within Warrant, without alteration or enlargement or any change whatsoever. 
  

 -3-Warrant 2 to M.A.G. Capital, LLC

 Exhibit 10.24 
 WARRANT TO PURCHASE COMMON STOCK 
 THIS WARRANT AND THE SECURITIES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE STATE
SECURITIES LAWS OR THE AVAILABILITY OF AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
 WARRANT TO PURCHASE COMMON STOCK 
  

			
	 Number of Shares:
	    	 Up to 3,250,000 Shares (subject to adjustment)

		
	 Warrant Price:
	    	 $1.3278 per Share

		
	 Issuance Date:
	    	 September 20, 2006

		
	 Expiration Date:
	    	 September 20, 2011

 THIS WARRANT CERTIFIES THAT for value received, M.A.G. Capital, LLC, or its registered assigns (hereinafter
called the “Holder”) is entitled to purchase from Diametrics Medical, Inc., a Minnesota corporation (hereinafter called the “Company”), the above referenced number of fully paid and nonassessable
shares (the “Shares”) of common stock, par value $1.00 per share (the “Common Stock”) of Company, at the Warrant Price per Share referenced above; the number of shares purchasable upon exercise of this
Warrant referenced above being subject to adjustment from time to time as described herein. This Warrant is issued in connection with that certain Warrant Subscription Agreement dated as of September 20, 2006, by and between the Company and
Holder (the “Subscription Agreement”). The exercise of this Warrant shall be subject to the provisions, limitations and restrictions contained herein. 
 1. Term and Exercise. 
 1.1 Term. This Warrant is exercisable in whole or in part (but not as to
any fractional share of Common Stock), at any time and from time to time after the later of (x) the date that is six months after the Issuance Date and (y) the date of approval (the “Shareholder Approval Date”) by the
shareholders of the Company of either (i) an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the number of shares of Common Stock that the Company is authorized to issue or (ii) the merger of the
Company into a wholly owned subsidiary of the Company incorporated in the State of Delaware, in either case resulting in a sufficient number of authorized shares for the Company to reserve a sufficient number of shares of authorized but unissued
shares of Common Stock issuable upon exercise of this Warrant, but prior to 6:00 p.m. (New York Time) on the Expiration Date set forth above. 
 1.2
Warrant Price. The Warrant shall be exercisable at the Warrant Price referenced above. 
 1.3 Maximum Number of Shares. The maximum
number of Shares of Common Stock exercisable pursuant to this Warrant is 3,250,000 Shares, subject to adjustment as set forth herein. However, notwithstanding anything herein to the contrary, in no event shall the Holder be permitted to exercise
this Warrant for a number of Shares greater than the number that would cause the aggregate beneficial ownership of the Company’s Common Stock (calculated pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of the Holder
and all persons affiliated with the Holder to equal 9.99% of the Company’s Common Stock then outstanding; provided that the Holder shall be responsible for any calculation required for compliance with such 9.99% limit and shall provide the
Company with a certificate setting forth such calculation at the time of any exercise of this Warrant in whole or in part. 
 1.4 Procedure for
Exercise of Warrant. Holder may exercise this Warrant by delivering the following to the principal office of the Company in accordance with Section 5.1 hereof: (i) a duly executed Notice of Exercise in substantially the form
attached as Schedule A and the certificate described in Section 1.3 hereof, (ii) payment of the Warrant Price then in effect for each of the Shares being purchased, as designated in the Notice of Exercise, and (iii) this Warrant.
Payment of the Warrant Price may be in cash, certified or official bank check payable to the order of the Company, or wire transfer of funds to the Company’s account (or any combination of any of the foregoing) in the amount of the Warrant
Price for each share being purchased. 
 1.5 Delivery of Certificate and New Warrant. In the event of any exercise of the rights represented by
this Warrant, a certificate or certificates for the shares of Common Stock so purchased, registered in the name of the Holder or such other name or names as may be designated by the Holder, together with any other securities or other property which
the Holder is entitled to receive upon exercise of this Warrant, shall be delivered to the Holder hereof, at the Company’s expense, within a reasonable time, not exceeding five (5) trading days, after the rights represented by this Warrant
shall have been so exercised; and, unless this Warrant has expired, a new Warrant representing the number of Shares (except a remaining fractional share), if any, with respect to which this Warrant shall not then have been exercised shall also be
issued to the Holder hereof within such time. The person in whose name any certificate for shares of Common Stock is issued upon exercise of this Warrant shall for all purposes be deemed to have become the holder of record of such shares on the date
on which the Warrant was surrendered and payment of the Warrant Price was received by the Company, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is on a date when the stock transfer
books of the Company are closed, such person shall be deemed to have become the holder of such Shares at the close of business on the next succeeding date on which the stock transfer books are open. 
 1.6 Restrictive Legend. Each certificate for Shares shall bear a restrictive legend in substantially the form as follows, together with any additional
legend required by (i) any applicable state securities laws and (ii) any securities exchange upon which such Shares may, at the time of such exercise, be listed: 
 “The shares represented by this certificate have not been registered under the Securities Act of 1933, as amended and may not be sold, offered for sale, transferred or pledged in the absence of such registration
or an exemption therefrom under such Act.” 
 Any certificate issued at any time in exchange or substitution for any certificate bearing such legend
shall also bear such legend unless, in the opinion of counsel for the Holder thereof (which counsel shall be reasonably satisfactory to the Company), the securities represented thereby are not, at such time, required by law to bear such legend.

 1.7 Fractional Shares. No fractional Shares shall be issuable upon exercise or conversion of the Warrant.
If a fractional share interest arises upon any exercise or conversion of the Warrant, the Company shall round up the number of Shares to be issued to the nearest whole Share and the Holder shall increase the consideration due upon exercise by an
amount computed by multiplying such fractional interest by the Warrant Price of a full Share then in effect. 
 1.8 Cashless Exercise.

 (a) Holder may, at its option, in lieu of paying the Warrant Price upon exercise of this Warrant pursuant to Section 1.4 hereof, elect
to receive instead a number of Shares computed using the following formula: 
 X=Y(A-B) 
           A 
 Where X= the number of Shares issuable to Holder upon exercise of this Warrant under this Section 1.8, Y=the number of Shares for which this Warrant is then being exercised, in whole or in part, A=the Fair Market
Value (as defined below) of one Share of Common Stock as of the exercise date; and B=the Warrant Price of one Share of Common Stock. 
 (b)
For purposes of this Section 1.8, “Fair Market Value” of one Share of Common Stock as of a particular date shall be determined as follows: (i) if traded on a national securities exchange or through the Nasdaq Stock
Market, the Fair Market Value shall be deemed to be the volume weighted average closing price of the Common Stock on such exchange for the five trading days immediately prior to the date the Holder delivers its Notice of Exercise to the Company (or
if no reported sales took place on any of the five days, the last five trading days on which any such sales took place prior to the date of such notice); (ii) if traded over-the-counter but not on the Nasdaq Stock Market, the Fair Market Value
shall be deemed to be the volume weighted average closing price of the Common Stock on such exchange for the five trading days immediately prior to the date the Holder delivers its Notice of Exercise to the Company (or if no reported sales took
place on any of the five days, the last five trading days on which any such sales took place prior to the date of such notice); and (iii) if not then traded on any public market, the Fair Market Value shall be the as mutually determined by the
Holder and the Company or, if the Holder and the Company are unable to reach such agreement, as determined by a nationally recognized independent investment banker or valuation consultant (which has not been retained by the Company or any of its
affiliates for the past two years preceding such determination) mutually acceptable to Holder and Company. 
 2. Representations, Warranties and
Covenants. 
 2.1 Representations and Warranties. 
 (a) The Company is a corporation duly organized, validly existing and in good standing under the laws of its state of incorporation and has all necessary power and authority to perform its obligations under this
Warrant; 
 (b) Subject to the Shareholder Approval, the execution, delivery and performance of this Warrant has been duly authorized by all
necessary actions on the part of the Company and constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms; and 
 (c) Subject to the Shareholder Approval, this Warrant does not violate and is not in conflict with any of the provisions of the Company’s Amended
and Restated Articles of Incorporation, Certificate of Designation, Bylaws and any resolutions of the Company’s Board of Directors or stockholders, or any agreement of the Company, and no event has occurred and no condition or circumstance
exists that might (with or without notice or lapse of time) constitute or result directly or indirectly in such a violation or conflict. 
 2.2
Issuance of Shares. The Company covenants and agrees that all shares of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be validly issued, fully paid and nonassessable, and
free from all taxes, liens and charges with respect to the issue thereof and shall be listed on any exchanges on which the Common Stock is then listed. The Company further covenants and agrees that it will pay when due and payable any and all
federal and state taxes which may be payable in respect of the issue of this Warrant or any Common Stock or certificates therefor issuable upon the exercise of this Warrant excluding the Holder’s income and other taxes not directly relating to
the issuance of the Warrant or Common Stock. The Company further covenants and agrees that the Company will at all times when this Warrant is exercisable have authorized and reserved, free from preemptive rights, a sufficient number of shares of
Common Stock to provide for the exercise in full of the rights represented by this Warrant. If at any time when this Warrant is exercisable the number of authorized but unissued shares of Common Stock of the Company shall not be sufficient to effect
the exercise of the Warrant in full, subject to the limitations set forth in Section 1.3 hereto, then the Company will use commercially reasonable efforts to take all such corporate action as may, in the opinion of counsel to the Company, be
necessary or advisable to increase the number of its authorized shares of Common Stock as shall be sufficient to permit the exercise of the Warrant in full, subject to the limitations set forth in Section 1.3 hereto, including without
limitation, using its commercially reasonable efforts to obtain any necessary stockholder approval of such increase. The Company further covenants and agrees that if any shares of capital stock to be reserved for the purpose of the issuance of
shares upon the exercise of this Warrant require registration with or approval of any governmental authority under any federal or state law before such shares may be validly issued or delivered upon exercise, then the Company will in good faith and
as expeditiously as possible endeavor to secure such registration or approval, as the case may be. Notwithstanding the foregoing, at the date of execution of this Warrant, the Corporation does not have sufficient authorized but unissued shares of
Common Stock for the purpose of effecting the conversion of this Warrant, and the Corporation will use commercially reasonable efforts to obtain the Shareholder Approval. If and so long as the Common Stock issuable upon the exercise of this Warrant
is listed on any national securities exchange or the Nasdaq Stock Market, the Company will, if permitted by the rules of such exchange or market, list and keep listed on such exchange or market, upon official notice of issuance, all shares of such
Common Stock issuable upon exercise of this Warrant. 
 3. Other Adjustments. 
 3.1 Subdivision or Combination of Shares. In case the Company shall at any time subdivide its outstanding Common Stock into a greater number of shares, the Warrant Price in effect immediately prior to
such subdivision shall be proportionately reduced, and the number of Shares subject to this Warrant shall be proportionately increased, and conversely, in case the outstanding Common Stock of the Company shall be combined into a smaller number of
shares, the Warrant Price in effect immediately prior to such combination shall be proportionately increased, and the number of Shares subject to this Warrant shall be proportionately decreased. 
 3.2 Dividends in Common Stock, Other Stock or Property. If at any time or from time to time the holders of Common Stock (or any shares of stock or other
securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled to receive, without payment therefor: 
 (a) Common Stock, Options or any shares or other securities which are at any time directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the
foregoing by way of dividend or other distribution; 
 (b) any cash paid or payable otherwise than as a regular cash dividend; or 

 

 -2- 

 (c) Common Stock or additional shares or other securities or property (including cash) by way of
spin-off, split-up, reclassification, combination of shares or similar corporate rearrangement (other than adjustments covered by the terms of Section 3.1 above or Section 3.3 below), then and in each such case (but without duplication),
the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other
securities and property (including cash in the cases referred to in clause (b) above and this clause (c)) which such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on
which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property. 
 3.3
Reorganization, Reclassification, Consolidation, Merger or Sale. If any recapitalization, reclassification or reorganization of the share capital of the Company, or any consolidation or merger of the Company with another corporation, or
the sale of all or substantially all of its shares and/or assets or other transaction (including, without limitation, a sale of substantially all of its assets followed by a liquidation) shall be effected in such a way that holders of Common Stock
shall be entitled to receive shares, securities or other assets or property (a “Change”), then, as a condition of such Change, lawful and adequate provisions shall be made by the Company whereby the Holder hereof shall
thereafter have the right to purchase and receive (in lieu of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby) such shares, securities or other assets or property
as may be issued or payable with respect to or in exchange for the number of outstanding shares of Common Stock which such Holder would have been entitled to receive had such Holder exercised this Warrant immediately prior to the consummation of
such Change. The Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to give effect
to the adjustments provided for in this Section 3 including, without limitation, adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new Warrant. The provisions of this Section 3.3
shall similarly apply to successive Changes. 
 4. Ownership and Transfer. 
 4.1 Ownership of This Warrant. The Company may deem and treat the person in whose name this Warrant is registered as the holder and owner hereof (notwithstanding any notations of ownership or writing
hereon made by anyone other than the Company) for all purposes and shall not be affected by any notice to the contrary until presentation of this Warrant for registration of transfer as provided in this Section 4. 
 4.2 Transfer and Replacement. This Warrant and all rights hereunder are transferable in whole or in part upon the books of the Company by the Holder hereof
in person or by duly authorized attorney, and a new Warrant or Warrants, of the same tenor as this Warrant but registered in the name of the transferee or transferees (and in the name of the Holder, if a partial transfer is effected) shall be made
and delivered by the Company upon surrender of this Warrant duly endorsed, at the office of the Company in accordance with Section 5.1 hereof. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft or
destruction, and, in such case, of indemnity or security reasonably satisfactory to it, and upon surrender of this Warrant if mutilated, the Company will make and deliver a new Warrant of like tenor, in lieu of this Warrant; provided that if the
Holder hereof is an instrumentality of a state or local government or an institutional holder or a nominee for such an instrumentality or institutional holder an irrevocable agreement of indemnity by such Holder shall be sufficient for all purposes
of this Warrant, and no evidence of loss or theft or destruction shall be necessary. This Warrant shall be promptly cancelled by the Company upon the surrender hereof in connection with any transfer or replacement. In the case of the loss, theft or
destruction of a Warrant, the Holder shall pay all expenses, taxes and other charges payable in connection with any transfer or replacement of this Warrant. Holder will not transfer this Warrant and the rights hereunder except in compliance with
federal and state securities laws and except after providing evidence of such compliance reasonably satisfactory to the Company. 
 5. Miscellaneous
Provisions. 
 5.1 Notices. Any notice or other document required or permitted to be given or delivered to the Holder shall be delivered
or forwarded to the Holder at c/o M.A.G. Capital, LLC, 555 South Flower Street, Suite 4200, Los Angeles, California 90071, Attention: David F. Firestone (Facsimile No. 213/553-8285), or to such other address or number as shall have been
furnished to the Company in writing by the Holder, with a copy to Latham & Watkins LLC, 633 West Fifth Street, Suite 4000, Los Angeles, California 90071-1448 Attention: Paul Tosetti (Facsimile No. 213/891-8763). Any notice or other
document required or permitted to be given or delivered to the Company shall be delivered or forwarded to the Company at 6033 West Century Blvd., Suite 850, Los Angeles, CA 90045 (facsimile No. (310) 670-4107), with a copy to
Sidley Austin LLP, 555 West Fifth Street, 40th Floor, Los Angeles, California 90013, Attention: Stephen D. Blevit
(Facsimile No. 213/896-6600), or to such other address or number as shall have been furnished to Holder in writing by the Company or to the Company by Holder. 
 5.2 All notices, requests and approvals required by this Warrant shall be in writing and shall be conclusively deemed to be given (i) when hand-delivered to the other party, (ii) when received if sent by facsimile at the
address and number set forth above; provided that notices given by facsimile shall not be effective, unless either (a) a duplicate copy of such facsimile notice is promptly given by depositing the same in the mail, postage prepaid and addressed
to the party as set forth below or (b) the receiving party delivers a written confirmation of receipt for such notice by any other method permitted under this paragraph; and further provided that any notice given by facsimile received after
5:00 p.m. (New York Time) or on a non-business day shall be deemed received on the next business day; (iii) five (5) business days after deposit in the United States mail, certified, return receipt requested, postage prepaid, and addressed
to the party as set forth below; or (iv) the next business day after deposit with an international overnight delivery service, postage prepaid, addressed to the party as set forth below with next business day delivery guaranteed; provided that
the sending party receives confirmation of delivery from the delivery service provider. 
 5.3 No Rights as Shareholder; Limitation of
Liability. This Warrant shall not entitle the Holder to any of the rights of a shareholder of the Company except upon exercise in accordance with the terms hereof. No provision hereof, in the absence of affirmative action by the Holder to
purchase shares of Common Stock, and no mere enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the Warrant Price hereunder or as a shareholder of the Company, whether such liability is
asserted by the Company or by creditors of the Company. 
 5.4 Governing Law. This Warrant shall be governed by and construed in accordance
with the laws of the State of New York. 
 5.5 Binding Effect on Successors. This Warrant shall be binding upon any corporation succeeding the
Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets and/or securities. All of the obligations of the Company relating to the Shares issuable upon the exercise of this Warrant shall survive the
exercise and termination of this Warrant. All of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the Holder. 
  

 -3- 

 5.6 Waiver, Amendments and Headings. This Warrant and any provision hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by both parties (either generally or in a particular instance and either retroactively or prospectively). The headings in this Warrant are for purposes of reference only and shall not
affect the meaning or construction of any of the provisions hereof. 
 5.7 Jurisdiction. Each of the parties irrevocably agrees that any and
all suits or proceedings based on or arising under this Agreement may be brought in the federal or state courts located in the City of New York, New York and consents to the jurisdiction of such courts for such purpose. Each of the parties
irrevocably waives the defense of an inconvenient forum to the maintenance of such suit or proceeding in any such court. Each of the parties further agrees that service of process upon such party mailed by first class mail to the address set forth
in Section 5.1 shall be deemed in every respect effective service of process upon such party in any such suit or proceeding. Nothing herein shall affect the right of a Holder to serve process in any other manner permitted by law. Each of the
parties agrees that a final non-appealable judgment in any such suit or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on such judgment or in any other lawful manner. 
 5.8 Attorneys’ Fees and Disbursements. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the
prevailing party or parties shall be entitled to receive from the other party or parties reasonable attorneys’ fees and disbursements in addition to any other relief to which the prevailing party or parties may be entitled. 
 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer this 20th day of September, 2006. 
  

					
	 COMPANY:
	 	DIAMETRICS MEDICAL, INC.
			
		 	 By:
	 	 /s/ W. Bruce Comer III
  

		 	 Print Name:
	 	 W. Bruce Comer III

		 	 Title:
	 	 Chief Executive Officer

  

 -4- 

 SCHEDULE A 
 FORM OF NOTICE OF EXERCISE 
 [To be signed only upon exercise of the Warrant]

 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO EXERCISE THE WITHIN WARRANT 
 The undersigned hereby elects to purchase
                     shares of Common Stock (the “Shares”) of Diametrics Medical, Inc. under the Warrant to Purchase
Common Stock dated September 18, 2006, which the undersigned is entitled to purchase pursuant to the terms of such Warrant. The undersigned has delivered $            , the
aggregate Warrant Price for                      Shares purchased herewith, in full in cash or by certified or official bank check or wire
transfer. Attached to this Notice of Exercise is a certificate showing the percentage ownership calculation required under Section 1.3 of the Warrant. 
 Please issue a certificate or certificates representing such shares of Common Stock in the name of the undersigned or in such other name as is specified below and in the denominations as is set forth below:

  

			
	  
	 [Type Name of Holder as it should appear on the stock certificate]

	  
	 [Requested Denominations – if no denomination is specified, a single certificate will be issued]

	
	 The initial address of such Holder to be entered on the books of Company shall be:

	  	 	
	  	 	
	  	 	

 The undersigned hereby represents and warrants that the undersigned is acquiring such shares for
his own account for investment purposes only, and not for resale or with a view to distribution of such shares or any part thereof. 
  

	
	 By:                                      
                                        
                  

	
	 Print
Name:                                       
                                       
 

	
	 Title:                                     
                                        
               

	
	 Dated:                                     
                                        
             

  

 -1- 

 FORM OF ASSIGNMENT 
 (ENTIRE) 
 [To be signed only upon transfer of entire Warrant] 
 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO TRANSFER THE WITHIN WARRANT 
 FOR VALUE RECEIVED
                                        
hereby sells, assigns and transfers unto                                  all
rights of the undersigned under and pursuant to the within Warrant, and the undersigned does hereby irrevocably constitute and appoint
                                 Attorney to transfer the said Warrant on the
books of Diametrics Medical, Inc., with full power of substitution. 
  

			
	  

	 [Type Name of Holder]

		
	 By:
	 	  

	 Title:
	 	  

	
	 Dated:
                    

 NOTICE 
 The
signature to the foregoing Assignment must correspond exactly to the name as written upon the face of the within Warrant, without alteration or enlargement or any change whatsoever. 
  

 -2- 

 FORM OF ASSIGNMENT 
 (PARTIAL) 
 [To be signed only upon partial transfer of Warrant] 
 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO TRANSFER THE WITHIN WARRANT 
 FOR VALUE RECEIVED
                                        
hereby sells, assigns and transfers unto
                                        
(i) the rights of the undersigned to purchase
                                 shares of Common Stock under and pursuant to the
within Warrant, and (ii) on a non-exclusive basis, all other rights of the undersigned under and pursuant to the within Warrant, it being understood that the undersigned shall retain, severally (and not jointly) with the transferee(s) named
herein, all rights assigned on such non-exclusive basis. The undersigned does hereby irrevocably constitute and appoint
                                 Attorney to transfer the said Warrant on the
books of Diametrics Medical, Inc., with full power of substitution. 
  

			
	  

	 [Type Name of Holder]

		
	 By:
	 	  

	 Title:
	 	  

	
	 Dated:
                    

 NOTICE 
 The
signature to the foregoing Assignment must correspond exactly to the name as written upon the face of the within Warrant, without alteration or enlargement or any change whatsoever. 
  

 -3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]